DATE |
PRESENTER |
TOPIC |
PAPERS |
10/18/2013 |
Gary Rosner |
Biomarker discovery & designs: review |
Papers for 18Oct2013.zip |
11/15/2013 |
Chiung-Yu Huang |
Competing risk |
|
12/20/2013 |
Hao Wang |
Phase III designs with development and validations of biomarkers |
|
01/17/2014 |
Peng Huang |
I-SPY Trials |
|
02/21/2014 |
Zheyu Wang |
ROC and Meta analysis |
|
03/21/2014 |
Chenguang Wang |
Enrichment design |
|
04/18/2014 |
Jay Herson |
The role of pCR (pathologic complete response) in accelerated approval for new treatments for early stage neoadjuvant breast cancer |
|
09/16/2014 |
|
Discussion of Topics |
|
10/21/2014 |
Ravi Varadhan |
Overview of multi-state models |
|
11/18/2014 |
Zhe Zhang, Chiung-Yu Huang |
Competing risks |
|
12/16/2014 |
Chiung-Yu Huang |
Continuation - Competing risks |
|
01/20/2015 |
Gary, Marianna, Hua-Ling |
Examples of applications of multi-state models |
|
02/17/2015 |
Chenguang Wang |
Overview of causal inference |
|
03/17/2015 |
|
Clinical trials as observational studies - Principal stratification & G+ (?) method |
|
04/21/2015 |
|
Introduction to bioinformatics |
|
05/19/2015 |
|
|
|
09/15/2015 |
|
Discussion of Topics |
|
10/20/2015 |
MedImmune Statisticians |
Drug combination studies |
|
11/17/2015 |
Ravi |
Reportnig follow-up times |
|
12/15/2015 |
|
CANCELLED |
|
01/19/2016 |
Yanxun Xu |
Design of Clinical Trial |
|
02/16/2016 |
Sarah J. Wheelan |
Introductory bioinformatics |
|
03/15/2016 |
CG, Brandon, Hao |
Next-generation clinical trials with an example basket trial |
|
04/19/2016 |
Ravi |
Precision medicine |
|
05/17/2016 |
Peng |
Statistical monitoring of clinical trials |
|
09/20/2016 |
|
Discussion of Topics |
|
10/18/2016 |
CG, Zheyu, Hao, and Gary |
MedImmune Biomarker Project |
|
11/15/2016 |
Jay Herson |
ER+ Early Stage Breast Cancer: Tamoxifen, Letrozole, Selective Crossover. What to Believe |
|
12/20/2016 |
|
CANCELLED - Pocock's Papers |
|
01/17/2017 |
Yu Du |
Combination Phase 1 studies |
|
02/21/2017 |
Hwanhee Hong |
Meta-Analysis of Rare Adverse Events in Randomized Clinical Trials: Bayesian and Frequentist Methods |
|
03/21/2017 |
Michael Rosenblum |
POSTPONED |
|
04/18/2017 |
Rob Scharpf |
Reproducible research |
|
05/16/2017 |
Gary Rosner |
Introduction to pharmacokinetics and pharmacodynamics |
|
09/19/2017 |
Group |
Discussion of proposed topics |
|
10/17/2017 |
Gary |
Some Techniques and Tools for Early Clinical Studies |
|
11/21/2017 |
Leslie |
Incorporation of Social Media in Clinical Research |
|
12/19/2017 |
Nicholas |
Classification: CART & BART |
|
01/16/2018 |
Yanxun |
Introduction to Bayesian nonparametrics |
|
02/20/2018 |
Chen |
Review Basket, Umbrella, and Platform Trial Designs |
|
03/20/2018 |
Jodi Segal |
Real World Data Repositories |
|
04/17/2018 |
Amanda |
Using SEER/Medicare Data |
|
05/15/2018 |
Franck Housseau |
Immunology Introduction |
|
09/18/2018 |
Group |
Discussion of Topics |
|
10/23/2018 |
Jay Herson |
False Positives in Cardiotoxicity Reporting |
|
11/20/2018 |
Rob Scharpf & Jacob Fiksel |
Copy Number Variation & NGS |
|
12/18/2018 |
Nick Henderson |
Subgroup analysis |
|
01/15/2019 |
Hao Wang & Su Jin Lim |
Multiple comparisons methods & tools |
|
02/19/2019 |
Ravi Varadhan |
Per-protocol vs intent-to-treat analyses |
HernanRobins PerProtocolAnalysesOfPragmaticTrials.pdf |
03/19/2019 |
Taxiarchis Botsis |
Natural Language Processing |
|
04/16/2019 |
CG Wang & Wei Fu |
R/Sweave, knitr, R markdown |
|
05/28/2019 |
Chen Hu & Kai Ding |
Delivery Methods in Radiation Oncology |
|
09/17/2019 |
Group |
Discussion of Topics |
|
10/15/2019 |
The Biostatistics Group |
Statistical Guidelines for Different Journals |
|
11/19/2019 |
Jay Herson |
Bias and Randomization 1980 - 2020 - 2060 |
|
12/17/2019 |
Daniel Scharfstein |
ITT, Per-protocol and Estimands |
|
01/21/2020 |
Challice Bonifant |
CAR-T cell therapy: A primer for Statisticians |
|
02/18/2020 |
Phil Prorok |
TBD |
|
03/17/2020 |
TBA |
|
|
04/21/2020 |
TBA |
|
|
05/19/2020 |
TBA |
|
|